220 related articles for article (PubMed ID: 529490)
1. Effect of a streptococcal preparation on the complement system.
Kato H; Yokoe N; Matsumura N; Nishida K; Ikezaki M; Hosokawa K; Hotta T; Takemura S; Yoshikawa T; Kondo M
Jpn J Exp Med; 1979 Oct; 49(5):343-50. PubMed ID: 529490
[TBL] [Abstract][Full Text] [Related]
2. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
Inada K
Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
[TBL] [Abstract][Full Text] [Related]
3. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
4. Effect of a protein-bound polysaccharide PS-K on the complement system.
Kato H; Yokoe N; Takemura S; Yoshikawa T; Furukawa Y; Kondo M
Res Exp Med (Berl); 1983; 182(2):85-94. PubMed ID: 6867480
[TBL] [Abstract][Full Text] [Related]
5. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
Kievits F; Kijlstra A
Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
[TBL] [Abstract][Full Text] [Related]
7. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.
Asghar SS; de Koster A; van der Helm HJ
Biochem Pharmacol; 1986 Sep; 35(17):2917-21. PubMed ID: 3638137
[TBL] [Abstract][Full Text] [Related]
8. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.
Bertazzi DT; de Assis-Pandochi AI; Talhaferro VL; Caleiro Seixas Azzolini AE; Pereira Crott LS; Arantes EC
Int Immunopharmacol; 2005 Jun; 5(6):1077-84. PubMed ID: 15829423
[TBL] [Abstract][Full Text] [Related]
9. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
Kitamura H; Tsuboi M; Nagaki K
Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
[TBL] [Abstract][Full Text] [Related]
10. Multiple effects of a diamidine (propamidine) on complement activation.
Vogt W; Hinsch B; Schmidt G; Von Zabern I
Immunology; 1979 Jan; 36(1):131-7. PubMed ID: 422224
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of organic solvents on immunity indicators in serum.
Stefanovic J; Starsia Z; Murgasová I; Absolonová O
J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):1-7. PubMed ID: 3571967
[TBL] [Abstract][Full Text] [Related]
12. Anisakis simplex: the activity of larval products on the complement system.
García-Hernández P; Rodero M; Cuéllar C
Exp Parasitol; 2007 Jan; 115(1):1-8. PubMed ID: 16777096
[TBL] [Abstract][Full Text] [Related]
13. Interactions of chrysotile asbestos fibres with the complement system.
Saint-Remy JM; Cole P
Immunology; 1980 Oct; 41(2):431-7. PubMed ID: 6904360
[TBL] [Abstract][Full Text] [Related]
14. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
Hunder GG; McDuffie FC; Clark RJ
J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858
[TBL] [Abstract][Full Text] [Related]
15. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
[TBL] [Abstract][Full Text] [Related]
16. Action of a new non-steroid anti-inflammatory drug, carprofen (Ro 20-5720) on activation of the complement system: an in vitro research.
Auteria A; Laghi Pasini F; Di Perri T
Int J Tissue React; 1982; 4(1):9-13. PubMed ID: 7085003
[TBL] [Abstract][Full Text] [Related]
17. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the classical and alternative pathways of human and guinea pig complement by pyran copolymer.
Webster GF; McArthur WP
Int Arch Allergy Appl Immunol; 1981; 66(3):304-9. PubMed ID: 6913544
[TBL] [Abstract][Full Text] [Related]
19. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]